Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Accumulated Expenses: 2023-2025

Historic Accumulated Expenses for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $275.6 million.

  • Ardent Health's Accumulated Expenses rose 792.46% to $275.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $275.6 million, marking a year-over-year increase of 792.46%. This contributed to the annual value of $295.1 million for FY2024, which is 1024.79% up from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Accumulated Expenses is $275.6 million, which was up 792.46% from $259.2 million recorded in Q2 2025.
  • Ardent Health's Accumulated Expenses' 5-year high stood at $295.1 million during Q4 2024, with a 5-year trough of $214.2 million in Q1 2025.
  • Moreover, its 3-year median value for Accumulated Expenses was $259.2 million (2025), whereas its average is $259.4 million.
  • Per our database at Business Quant, Ardent Health's Accumulated Expenses surged by 1024.79% in 2024 and then skyrocketed by 434.94% in 2025.
  • Over the past 3 years, Ardent Health's Accumulated Expenses (Quarter) stood at $267.7 million in 2023, then grew by 10.25% to $295.1 million in 2024, then dropped by 6.61% to $275.6 million in 2025.
  • Its Accumulated Expenses stands at $275.6 million for Q3 2025, versus $259.2 million for Q2 2025 and $214.2 million for Q1 2025.